Patents Examined by Juliet Switzer
  • Patent number: 7998670
    Abstract: Methods for detecting cancer that include hybridizing a set of chromosomal probes to a biological sample obtained from a patient, and identifying if aneusomic cells are present in a selected subset of cells obtained from the biological sample are described. A set of chromosomal probes and kits for detecting cancer that include sets of chromosomal probes, are also described.
    Type: Grant
    Filed: May 21, 2007
    Date of Patent: August 16, 2011
    Assignees: Mayo Foundation for Medical Education and Research, Vysis, Inc.
    Inventors: Kevin C. Halling, Robert B. Jenkins, Walter King, Irina A. Sokolova, Steven A. Seelig
  • Patent number: 7262004
    Abstract: An in vitro screening method for identifying insect tolerant genotypes or clones is described. The method comprises growing plantlets in an in vitro system, screening the plantlets for molecular variation of somaclones using RAPD analysis in vitro, selecting the somaclones having molecular variation, exposing the somaclones to insect larvae or nymphs and identifying the surviving somaclones.
    Type: Grant
    Filed: January 18, 2000
    Date of Patent: August 28, 2007
    Assignee: Council of Scientific and Industrial Research
    Inventors: Suman Preet Singh Khanuja, Ajit Kumar Shasany, Sunita Dhawan, Mahendra Pandurang Darokar, Sarita Satapathy, Tiruppadiripuliyur Ranganathan Santha Kumar, Dharmendra Saikia, Nirmal Kumar Patra, Janak Raj Bahl, Arun Kumar Tripathy, Sushil Kumar
  • Patent number: 6670124
    Abstract: A method for determining an HLA genotype of a subject is disclosed. The method comprises (a) isolating template nucleic acid from the subject; (b) amplifying the template nucleic acid to generate sufficient product for each allele of at least one gene locus to be determined; (c) hybridizing the template nucleic acid with an immobilized array of capture oligonucleotides, each having a known nucleic acid sequence of an HLA allele; and (d) determining the particular capture oligonucleotide to which the template nucleic acid hybridizes, thereby determining the genotype of the subject. A number of additional methods that can eliminate or abbreviate additional steps are also described. Moreover, the present invention provides a method for determining tissue compatibility using the determined HLA genotype.
    Type: Grant
    Filed: December 20, 2000
    Date of Patent: December 30, 2003
    Assignee: StemCyte, Inc.
    Inventors: Robert Chow, Richard Tonai